Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts Details-
Title Grant Type Focus Area Country Application Due Date Real World Evidence on the Impact of Early and Appropriate Use of Aztreonam-Avibactam (ATM-AVI)Release Date:Research Inflammation & Immunology Brazil, Chile, India, Italy, South Africa, Spain, United Kingdom Guideline Concordant Care and New Data for Patients with MIBC through la/mUCEducation Oncology USA Clinical Research Studies of Atirmociclib in HR+/HER2- and/or HER2+ Breast CancerRelease Date:Research Oncology Australia, Brazil, Canada, China, France, Germany, Italy, Japan, Korea, Mexico, Spain, Taiwan, USA, United Kingdom Quality Improvement Interventions to Enhance the Care of Patients Infected by MBL-CRE or S. maltophiliaRelease Date:Quality Improvement Inflammation & Immunology Australia, Chile, India, Italy, Spain, United Kingdom Advancing Real-World Evidence in Idiopathic Inflammatory Myopathies Through a German Disease RegistryRelease Date:Research Inflammation & Immunology Germany Real-World Evidence on Clinical Outcomes with ATM-AVI in Adult Patients with Stenotrophomonas maltophilia InfectionsRelease Date:Research Inflammation & Immunology China Real-World Evidence on Clinical Outcomes with Aztreonam-Avibactam (ATM-AVI) in Adult Patients with Limited Treatment OptionsRelease Date:Research Inflammation & Immunology China Tissue Penetration and Correlation with Clinical Outcomes of ATM-AVI in Adult Patients with Limited Treatment OptionsRelease Date:Research Inflammation & Immunology China Advancing Multidisciplinary Care in HemophiliaRelease Date:Quality Improvement Rare Disease China BCMA BsAb Educational Initiatives in 2L+ Relapsed/Refractory Multiple MyelomaRelease Date:Education Oncology USA -
Title Grant Type Focus Area Country Application Due Date Cardiac Transthyretin Amyloid (ATTR) FellowshipRelease Date:Partner: International Society of AmyloidosisFellowship Rare Disease All Early Diagnosis of Invasive Fungal Infections(Europe, Australia, New Zealand, Korea and Japan)Release Date:Research Hospital All Pfizer and RCNi – Providing Access to Learning Resources for Nurses in Emerging Markets AsiaEducation Support for the Professions Hong Kong, India, Indonesia, Malaysia, Pakistan, Philippines, Singapore, Taiwan, Thailand, Vietnam Improving Real-World Evidence & Data Generation Skills in Latin AmericaRelease Date:Education Support for the Professions All Optimizing Venous Thromboembolism Management in Latin AmericaRelease Date:Quality Improvement Internal Medicine All Alopecia Areata, Atopic Dermatitis and Vitiligo (Global)Release Date:Research Inflammation & Immunology All Relapsed/Refractory Multiple MyelomaRelease Date:Education Oncology USA Antimicrobial Stewardship (AMS) Programs to Address Health Inequities in Resource Limited SettingsRelease Date:Partner: Global Bridges at Mayo ClinicQuality Improvement Hospital All Increase HCP knowledge of Gene Therapy managementRelease Date:Education Rare Disease China Burden of Pneumococcal Disease - Analyzing Local Surveillance Data (Asia, Africa, Latin America, and Middle East)Release Date:Research Vaccines All Pre-clinical & Translational Research in Multiple MyelomaRelease Date:Research Oncology All Acute Lymphoblastic Leukemia Peer-to-Peer Education & SupportRelease Date:Education Oncology USA